Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Jun;85(6):652–658. doi: 10.1111/j.1349-7006.1994.tb02409.x

Chemotherapy Targeting Regional Lymph Nodes by Gastric Submucosal Injection of Liposomal Adriamycin in Patients with Gastric Carcinoma

Yoshimi Akamo 1,✉, Isamu Mizuno 1, Toshihisa Yotsuyanagi 2, Tatsuo Ichino 1, Noritaka Tanimoto 1, Tetsuya Yamamoto 1, Mariko Nagata 2, Hiromitsu Takeyama 1, Nagao Shinagawa 1, Jiro Yura 1, Tadao Manabe 1
PMCID: PMC5919527  PMID: 8063620

Abstract

We investigated the delivery of adriamycin (ADR) to the regional lymph nodes of the stomach following the gastric submucosal injection of liposomal adriamycin (Lipo‐ADR) in 34 gastric carcinoma patients, as well as following intravenous administration of free ADR (F‐ADR) in another 18 patients. Prior to radical gastrectomy, Lipo‐ADR was endoscopically injected into the gastric submucosa adjacent to the primary tumor via a needle‐tipped catheter. After Lipo‐ADR injection, the ADR concentration in the primary and secondary drainage lymph nodes was higher than in the other regional lymph nodes. Thus, the regional nodes more susceptible to metastasis showed higher levels of ADR. In contrast, the intravenous administration of F‐ADR produced a similar and far lower ADR concentration in all the nodes. Delivery of ADR to the primary drainage lymph nodes following injection of 5 ml of Lipo‐ADR was compared with delivery to the left gastric artery lymph nodes after intravenous administration of an equal dose of F‐ADR. The ADR levels (μg/g) after gastric submucosal injection were 15.1±8.30 on day 1 (n = 4); and 11.9±4.80 on day 4 (n = 6). Those after intravenous administration were 0.29±0.10 on day 1 (n = 4); and 0.36±0.0 on day 4 (n = 2). The differences between the two groups were significant (P<0.05). The ADR levels after the gastric submucosal injection were far higher than those after intravenous administration. These findings indicate that the gastric submucosal injection of Lipo‐ADR can specifically deliver ADR to the regional lymph nodes at high concentrations. Such preoperative adjuvant chemotherapy targeting the regional lymph nodes may be useful for preventing the lymph node recurrence of gastric carcinoma.

Keywords: Regional lymph node, Chemotherapy, Gastric carcinoma, Gastric submucosal injection, Liposomal adriamycin

Full Text

The Full Text of this article is available as a PDF (623.6 KB).

REFERENCES

  • 1. ) Ichiyoshi , Y. , Toda , T. , Minamisono , Y. , Nagasaki , S. , Yakeishi , Y. and Sugimachi , K.Recurrence in early gastric cancer . Surgery , 107 , 489 – 495 ( 1990. ). [PubMed] [Google Scholar]
  • 2. ) Kitaoka , H. , Yoshikawa , K. , Hirota , T. and Itabashi , M.Surgical treatment of early gastric cancer . Jpn. J. Clin. Oncol. , 14 , 283 – 293 ( 1984. ). [PubMed] [Google Scholar]
  • 3. ) Hagiwara , A. , Ahn , T. , Ueda , T. , Iwamoto , A. , Torii , T. and Takahashi , T.Anticancer agents absorbed by activated carbon particles; a new form of dosage enhancing efficacy on lymphnodal metastasis . Anticancer Res. , 6 , 1005 – 1008 ( 1985. ). [PubMed] [Google Scholar]
  • 4. ) Hagiwara , A. , Takahashi , T. , Ueda , T. , Iwamoto , A. and Torii , T.Activated carbon particles as anticancer drug carrier into regional lymph nodes . Anticancer Drug Des. , 1 , 313 – 321 ( 1987. ). [PubMed] [Google Scholar]
  • 5. ) Cater , S. K.Adriamycin, a review . J. Natl. Cancer Inst. , 55 , 1265 – 1274 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Young , R. C. , Ozols , R. F. and Myers , C. E.The anthracycline antineoplastic drugs . N. Engl. J. Med. , 305 , 139 – 153 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Rupniak , H. T. , Whelan , R. D. H. and Hill , B. T.Concentration and time‐dependent inter‐relationships for anti‐tumor drug cytotoxicities against tumor cells in vitro . Int. J. Cancer , 32 , 7 – 12 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Minow , R. A. , Benjamin , R. S. and Gottlieb , J. A.Adriamycin (NSC‐123127) cardiomyopathy: an overview with determination of risk factors . Cancer Chemother. Rep. , 6 , 195 – 201 ( 1975. ). [Google Scholar]
  • 9. ) Akamo , Y. , Mizuno , I. , Yotsuyanagi , T. , Ichino , T. and Tanimoto , N.Gastric submucosal administration of adriamycin for lymph node‐targeting in rabbits . Nagoya Med. J. , 36 , 233 – 242 ( 1992. ). [Google Scholar]
  • 10. ) Akamo , Y. , Yotsuyanagi , T. , Mizuno , I. , Ichino , T. , Tanimoto , N. , Kurahashi , S. , Saito , T. , Yamamoto , T. , Yasui , T. , Itabashi , Y. and Yura , J.Delivery of lymph node‐targeted adriamycin by gastric submucosal liposomal injection in rabbits . Jpn. J. Cancer Res. , 84 , 208 – 213 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Hirano , K. and Hant , C.Lymphatic transport of liposome‐encapsulated agents: effects of liposome size following intraperitoneal administration . J. Pharm. Sci. , 74 , 915 – 921 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Perez‐Soler , R. , Lopez‐Berestein , G. , Jahns , M. , Wright , K. and Kasi , L. P.Distribution of radiolabeled multi‐lamellar liposomes injected intralymphatically and sub‐cutaneously . Int. J. Nucl. Biol. , 12 , 261 – 266 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Mangat , S. and Patel , H. M.Lymph node localization of non‐specific antibody‐coated liposomes . Life Sci. , 36 , 1917 – 1925 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Szoka , F. and Papahadjopoulos , D.Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse‐phase evaporation . Proc. Natl. Acad. Sci. USA , 75 , 4194 – 4198 ( 1978. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Japanese Research Society for Gastric Cancer . “ The General Rules for the Gastric Cancer Study, The 11th Edition ,” pp. 1 – 146 ( 1985. ). Kanehara Shuppan; , Tokyo ( in Japanese ). [Google Scholar]
  • 16. ) Masuike , T. , Odake , J. and Takemoto , Y.Determination of adriamycin and its metabolites in biological samples using high performance liquid chromatography. II. Analysis of tissues by extraction method . J. Pharm. Soc. Jpn. , 104 , 620 – 623 ( 1984. ) ( in Japanese ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Takahashi , T. , Mizuno , M. , Fujita , Y. , Ueda , S. , Nishioka , B. and Majima , S.Increased concentration of anticancer agents in regional lymph nodes by fat emulsion, with special reference to chemotherapy of metastasis . Gann , 64 , 345 – 350 ( 1973. ). [PubMed] [Google Scholar]
  • 18. ) Tanigawa , N. , Satomura , K. , Hikasa , Y. , Hashida , M. , Muranishi , S. and Sezaki , H.Surgical chemotherapy against lymph node metastases: an experimental study . Surgery , 87 , 147 – 152 ( 1980. ). [PubMed] [Google Scholar]
  • 19. ) Takakura , Y. , Matsumoto , S. , Hashida , M. and Sezaki , H.Enhanced lymphatic delivery of mitomycin C conjugated with dextran . Cancer Res. , 44 , 2505 – 2510 ( 1984. ). [PubMed] [Google Scholar]
  • 20. ) Forssen , E. A. and Tokes , Z. A.Attenuation of dermal toxicity of doxorubicin by liposome encapsulation . Cancer Treat. Rep. , 67 , 481 – 484 ( 1983. ). [PubMed] [Google Scholar]
  • 21. ) Gasparini , G. , Toffoli , G. , Berlanda , G. and Rossi , C.A pharmacological rationale for neoadjuvant chemotherapy with adriamycin in locally advanced breast cancer . Anticancer Res. , 10 , 193 – 196 ( 1990. ). [PubMed] [Google Scholar]
  • 22. ) Speth , P. A. J. , Linssen , P. C. M. , Holdrinet , R. S. G. and Haanen , C.Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety‐six‐hour continuous infusion . Clin. Pharmacol. Ther. , 41 , 661 – 665 ( 1987. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES